3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like The Verdict Is In: ConMed???s SurgiQuest Liable for $2.2 Million in Compensatory Damages April 11, 2017 Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress September 28, 2017 Insmed Rockets as Lung Drug Wows in Late-Stage Study September 4, 2017
The Verdict Is In: ConMed???s SurgiQuest Liable for $2.2 Million in Compensatory Damages April 11, 2017
Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress September 28, 2017
